PDCD1 and inflammatory bowel disease: An increasing number of studies support the involvement of PD-1 and Treg interactions in the onset of different autoimmune conditions such as insulin-dependent diabetes mellitus (Type 1 diabetes, T1D), psoriasis, vitiligo, systemic lupus erythematosus (SLE) and inflammatory bowel diseases (IBD).